ClassID:

97123

C07K16/1207 - CPC Classification

Classification description:

Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Spirochaetales (O), e.g. Treponema, Leptospira

Recent Application in this class:
#1
20260070950
2026-03-12

MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO

#2
20250298019
2025-09-25

BORRELIA BURGDORFERI PEPTIDOGLYCAN DETECTION METHODS

#3
20240277823
2024-08-22

LEPTOSPIRAL VIRULENCE MODULATING PROTEINS AND USES THEREOF

#4
20240248100
2024-07-25

SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY

#5
20230391857
2023-12-07

METHODS OF TREATING INFECTIONS BY BLOCKING PATHOGEN MIMICS OF CD47

#6
20230322869
2023-10-12

MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO

#7
20230295245
2023-09-21

MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO

#8
20220380443
2022-12-01

TARGETING NAPA-LINKED PEPTIDOGLYCAN FOR TREATING LYME DISEASE

#9
20220185851
2022-06-16

Mutant fragments of OspA and methods and uses relating thereto

#10
20220106385
2022-04-07

USE OF MODIFIED HIV-1 FOR GENERATING FULLY HUMAN ANTIBODIES

#11
20210140980
2021-05-13

SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY

#12
20210054032
2021-02-25

Mutant fragments of OspA and methods and uses relating thereto

#13
20200239525
2020-07-30

Mutant fragments of OspA and methods and uses relating thereto

#14
20190284261
2019-09-19

DNA ANTIBODY CONSTRUCTS FOR USE AGAINST LYME DISEASE

#15
20190062409
2019-02-28

Generation of human anti-HIV-1 ENV monoclonal antibodies with neutralizing activity from humanized mice infected with HIV-1

#16
20180362593
2018-12-20

Mutant fragments of OspA and methods and uses relating thereto

#17
20180327460
2018-11-15

Mutant fragments of OspA and methods and uses relating thereto

#18
20180275126
2018-09-27

Polyvalent chimeric OspC vaccinogen and diagnostic antigen

#19
20180186867
2018-07-05

PROTEINS WITH REPETITIVE BACTERIAL-IG-LIKE (BIG) DOMAINS PRESENT IN LEPTOSPIRA SPECIES

#20
20170226193
2017-08-10

Anti-OSPA antibodies and methods of use

#21
20170114106
2017-04-27

Lyme disease vaccine

#22
20170101446
2017-04-13

Mutant fragments of OspA and methods and uses relating thereto

#23
20170037114
2017-02-09

Proteins with repetitive bacterial-IG-like (Big) domains present in species

#24
20160333056
2016-11-17

Mutant fragments of OspA and methods and uses relating thereto

#25
20160266112
2016-09-15

VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA

#26
20150232517
2015-08-20

MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO

#27
20150064208
2015-03-05

Polyvalent chimeric OSPC vaccinogen and diagnostic antigen

#28
20150004623
2015-01-01

DIAGNOSTIC KIT FOR THE DETECTION OF EARLY ACUTE LEPTOSPIROSIS

#29
20140348867
2014-11-27

Isolated Brachyspira and Methods and Compositions for Expanding and Isolating Brachyspira

#30
20140271501
2014-09-18

Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities

#31
20140248272
2014-09-04

RECOMBINANT PROTEINS FOR USE IN VACCINE, ANTIBODIES AGAINST SAID PROTEINS, AND DIAGNOSTIC AND THERAPEUTIC METHODS INCLUDING THE SAME

#32
20140212451
2014-07-31

Lyme disease vaccine

#33
20140030284
2014-01-30

Compositions comprising chimeric OSPA molecules and methods of use thereof

#34
20130266606
2013-10-10

Polyvalent chimeric OspC vaccinogen and diagnostic antigen

#35
20130245234
2013-09-19

Vmp-like sequences of pathogenic

#36
20120270301
2012-10-25

Proteins with repetitive bacterial-Ig-like (Big) domains present in species

#37
20120122238
2012-05-17

VMP-like sequences of pathogenic

#38
20120121639
2012-05-17

Proteins with repetitive Bacterial-Ig-like (Big) domains present in species

#39
20110311570
2011-12-22

Proteins with repetitive bacterial-Ig-like (Big) domains present in species

#40
20110262475
2011-10-27

LYME DISEASE VACCINE

#41
20110182924
2011-07-28

Proteins with repetitive Bacterial-Ig-like (Big) domains present in species

#42
20110064761
2011-03-17

NOVEL SEQUENCES OF BRACHYSPIRA, IMMUNOGENIC COMPOSITIONS, METHODS FOR PREPARATION AND USE THEREOF

#43
20110020800
2011-01-27

Characterization of BBK07 antigen of and methods of use

#44
20100317026
2010-12-16

VMP-like sequences of pathogenic

#45
20100297178
2010-11-25

NOVEL GENES AND PROTEINS OF BRACHYSPIRA HYODYSENTERIAE AND USE OF SAME FOR DIAGNOSIS AND THERAPY

#46
20100183656
2010-07-22

Proteins with repetitive Bacterial-Ig-like (Big) domains present in species

#47
20090155849
2009-06-18

GENERATION OF SPECIFIC ADHESION IN GRAM-NEGATIVE BACTERIA BY MEANS OF ANCHORING IMMUNOGLOBULIN SINGLE DOMAINS ON THEIR SURFACE WITH AUTOTRANSPORTERS

#48
20070197432
2007-08-23

Peptides for preventing, diagnosing and treating animal and/or human leptospirosis

#49
20070117970
2007-05-24

VMP-like sequences of pathogenic

#50
20070110764
2007-05-17

Proteins with repetitive bacterial-Ig-like (big) domains present in species

#51
20070020286
2007-01-25

Recombinant constructs of

#52
20060198849
2006-09-07

Preparation method of igy for preventing and cure mouth disease and the toothpaste base on the igy

#53
20050271682
2005-12-08

Recombinant constructs of

#54
20050176947
2005-08-11

Optical recording apparatus using one-dimensional diffractive light modulator

#55
14799553
2017-04-04

Immunotherapy for lyme disease